Evaluation of Current Methods to Detect Cellular Leucine-Rich Repeat Kinase 2 (LRRK2) Kinase Activity
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of Current Methods to Detect Cellular Leucine-Rich Repeat Kinase 2 (LRRK2) Kinase Activity
Authors
Keywords
-
Journal
Journal of Parkinsons Disease
Volume -, Issue -, Pages 1-25
Publisher
IOS Press
Online
2022-05-20
DOI
10.3233/jpd-213128
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity
- (2022) Adrienne E.D. Stormo et al. JOURNAL OF CELL BIOLOGY
- Preclinical modeling of chronic inhibition of the Parkinson’s disease associated kinase LRRK2 reveals altered function of the endolysosomal system in vivo
- (2021) Jillian H. Kluss et al. Molecular Neurodegeneration
- Structural analysis of the full-length human LRRK2
- (2021) Alexander Myasnikov et al. CELL
- Highly accurate protein structure prediction with AlphaFold
- (2021) John Jumper et al. NATURE
- LRRK2 Kinase Inhibitor Rejuvenates Oxidative Stress-Induced Cellular Senescence in Neuronal Cells
- (2021) Dong Hwan Ho et al. Oxidative Medicine and Cellular Longevity
- PDB ‐101: Educational resources supporting molecular explorations through biology and medicine
- (2021) Christine Zardecki et al. PROTEIN SCIENCE
- LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits
- (2020) Marco A. S. Baptista et al. Science Translational Medicine
- The In Situ Structure of Parkinson’s Disease-Linked LRRK2
- (2020) Reika Watanabe et al. CELL
- Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity
- (2020) An Phu Tran Nguyen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protein synthesis is suppressed in sporadic and familial Parkinson’s disease by LRRK2
- (2020) Prasannakumar Deshpande et al. FASEB JOURNAL
- Structure of LRRK2 in Parkinson’s disease and model for microtubule interaction
- (2020) C. K. Deniston et al. NATURE
- Divergent Effects of G2019S and R1441C LRRK2 Mutations on LRRK2 and Rab10 Phosphorylations in Mouse Tissues
- (2020) Lucia Iannotta et al. Cells
- Development of a multiplexed targeted mass spectrometry assay for LRRK2-phosphorylated Rabs and Ser910/Ser935 biomarker sites
- (2020) Raja S. Nirujogi et al. BIOCHEMICAL JOURNAL
- Endogenous Rab29 does not impact basal or stimulated LRRK2 pathway activity
- (2020) Alexia F. Kalogeropulou et al. BIOCHEMICAL JOURNAL
- Centrosomal cohesion deficits as cellular biomarker in lymphoblastoid cell lines from LRRK2 Parkinson's disease patients
- (2019) Belén Fernández et al. BIOCHEMICAL JOURNAL
- RAB8, RAB10 and RILPL1 contribute to both LRRK2 kinase-mediated centrosomal cohesion and ciliogenesis deficits
- (2019) Antonio Jesús Lara Ordóñez et al. HUMAN MOLECULAR GENETICS
- Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
- (2019) Mike A Nalls et al. LANCET NEUROLOGY
- The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human
- (2018) Rafeeq Mir et al. BIOCHEMICAL JOURNAL
- LRRK2 activation in idiopathic Parkinson’s disease
- (2018) Roberto Di Maio et al. Science Translational Medicine
- Frequency of Loss of Function Variants in LRRK2 in Parkinson Disease
- (2018) Cornelis Blauwendraat et al. JAMA Neurology
- A pathway for Parkinson’s Disease LRRK2 kinase to block primary cilia and Sonic hedgehog signaling in the brain
- (2018) Herschel S Dhekne et al. eLife
- GTP binding regulates cellular localization of Parkinson's disease-associated LRRK2
- (2017) Marian Blanca Ramírez et al. HUMAN MOLECULAR GENETICS
- LRRK2 phosphorylates membrane-bound Rabs and is activated by GTP-bound Rab7L1 to promote recruitment to the trans-Golgi network
- (2017) Zhiyong Liu et al. HUMAN MOLECULAR GENETICS
- Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry
- (2017) Annie J. Lee et al. MOVEMENT DISORDERS
- Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis
- (2017) Martin Steger et al. eLife
- PAK6 Phosphorylates 14-3-3γ to Regulate Steady State Phosphorylation of LRRK2
- (2017) Laura Civiero et al. Frontiers in Molecular Neuroscience
- Elevated LRRK2 autophosphorylation in brain-derived and peripheral exosomes in LRRK2 mutation carriers
- (2017) Shijie Wang et al. Acta Neuropathologica Communications
- G2019S-LRRK2 Expression Augments -Synuclein Sequestration into Inclusions in Neurons
- (2016) L. A. Volpicelli-Daley et al. JOURNAL OF NEUROSCIENCE
- Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
- (2016) Martin Steger et al. eLife
- Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration
- (2015) João P. L. Daher et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- LRRK2 localizes to endosomes and interacts with clathrin-light chains to limit Rac1 activation
- (2014) A. M. Schreij et al. EMBO REPORTS
- Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents
- (2014) Andrew B. West et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Ten Years and Counting: Moving Leucine-Rich RepeatKinase 2 Inhibitors to the Clinic
- (2014) Andrew B. West MOVEMENT DISORDERS
- Phosphorylation of LRRK2 by casein kinase 1α regulates trans-Golgi clustering via differential interaction with ARHGEF7
- (2014) Ruth Chia et al. Nature Communications
- Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies
- (2013) Paul Davies et al. BIOCHEMICAL JOURNAL
- LRRK2 kinase activity mediates toxic interactions between genetic mutation and oxidative stress in a Drosophila model: Suppression by curcumin
- (2012) Dejun Yang et al. NEUROBIOLOGY OF DISEASE
- The IkappaB Kinase Family Phosphorylates the Parkinson’s Disease Kinase LRRK2 at Ser935 and Ser910 during Toll-Like Receptor Signaling
- (2012) Nicolas Dzamko et al. PLoS One
- Ser1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations
- (2012) Z. Sheng et al. Science Translational Medicine
- A generalizable hypothesis for the genetic architecture of disease: pleomorphic risk loci
- (2011) A. Singleton et al. HUMAN MOLECULAR GENETICS
- LRRK2 Parkinson disease mutations enhance its microtubule association
- (2011) Lauren R. Kett et al. HUMAN MOLECULAR GENETICS
- A Rat Model of Progressive Nigral Neurodegeneration Induced by the Parkinson's Disease-Associated G2019S Mutation in LRRK2
- (2011) J. Dusonchet et al. JOURNAL OF NEUROSCIENCE
- 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
- (2010) R. Jeremy Nichols et al. BIOCHEMICAL JOURNAL
- Reevaluation of Phosphorylation Sites in the Parkinson Disease-associated Leucine-rich Repeat Kinase 2
- (2010) Xiaojie Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
- (2010) Mark R. Cookson NATURE REVIEWS NEUROSCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now